Comparison of clinical features of COVID‐19 infection in children with asthma and their healthy peers
Authors:
- 3 May 2022
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 57 (7) , 1693-1700
Abstract
Aim We aimed to assess the impact of COVID-19 on asthma exacerbations and to compare the severity of symptoms of SARS-CoV-2 infection of asthmatic children with those of healthy children. Methods The clinical course of COVID-19 was compared among 89 children with asthma and 84 healthy children with age- and gender-matched. Demographic factors, severity of asthma, duration of asthma, presence of atopy, type of treatment, and compliance to treatment in asthmatic children on clinical course of infection and to determine the risk factors for severe course for asthma exacerbation during COVID-19 were evaluated retrospectively. Demographic characteristics, clinical symptoms, duration of complaints, and hospitalization rates were statistically compared between the two groups. Results Both groups had similar rates of symptomatic disease, hospitalization, and duration of fever. Among children with asthma mean age was 10.3 years, 59.6% were male, and 84.3% had mild asthma. Dyspnea was more prevalent in asthmatic children (p:0.012), but other clinical findings were not different from those of healthy controls. 12.4% (n:11) of asthmatic children had asthma exacerbation, 2.2% (n:2) of them were hospitalized; one (1.1%) of which was due to asthma exacerbation. Conclusion The course of COVID-19 in patients with mild to moderate asthma, who were followed up regularly and who were compliant with their treatment, was similar to their healthy peers. Since there was no severe asthma case in our study, the results could not have been generalized to all asthmatic patients. Further comprehensive and multicenter studies are required in pediatric population.Keywords
This publication has 18 references indexed in Scilit:
- Asthma among hospitalized patients with COVID-19 and related outcomesJournal of Allergy and Clinical Immunology, 2020
- COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centresERJ Open Research, 2020
- Impact of the COVID-19 pandemic in children with allergic asthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort studyThe Lancet Child & Adolescent Health, 2020
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020
- Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2Journal of Allergy and Clinical Immunology, 2020
- The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United StatesJournal of the Pediatric Infectious Diseases Society, 2020
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across TissuesCell, 2020
- Inhaled corticosteroids and COVID-19: a systematic review and clinical perspectiveEuropean Respiratory Journal, 2020
- Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature reviewArchives of Virology, 2018